Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

DTCFF

Defence Therapeutics (QB) (DTCFF)

Defence Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:DTCFF
DatumZeitQuelleÜberschriftSymbolFirma
16/02/202216h00InvestorsHub NewsWireDEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
26/01/202214h49InvestorsHub NewsWireDefence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9USOTC:DTCFFDefence Therapeutics Inc (QB)
30/11/202118h32InvestorsHub NewsWireDEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENTUSOTC:DTCFFDefence Therapeutics Inc (QB)
23/11/202114h24InvestorsHub NewsWireDEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
09/11/202117h50InvestorsHub NewsWireDEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORSUSOTC:DTCFFDefence Therapeutics Inc (QB)
03/11/202113h11InvestorsHub NewsWireVACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITSUSOTC:DTCFFDefence Therapeutics Inc (QB)
13/10/202115h15InvestorsHub NewsWireDEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
06/10/202115h32InvestorsHub NewsWireDEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMAUSOTC:DTCFFDefence Therapeutics Inc (QB)
29/09/202114h30InvestorsHub NewsWireDEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCERUSOTC:DTCFFDefence Therapeutics Inc (QB)
20/09/202116h01InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALSUSOTC:DTCFFDefence Therapeutics Inc (QB)
14/09/202114h13InvestorsHub NewsWireDEFENCE THERAPEUTICS SUCCESS IN TESTING IT'S COVID-19 ACCUVAC-PT001 VACCINE IN A NON-RODENT MODELUSOTC:DTCFFDefence Therapeutics Inc (QB)
07/09/202113h35InvestorsHub NewsWireDEFENCE THERAPEUTICS DEVELOPMENT PROGRAM TO ENGINEER A NEW HPV VACCINE INITIATEDUSOTC:DTCFFDefence Therapeutics Inc (QB)
01/09/202116h39InvestorsHub NewsWireThe vaccination specialist is about to become popularUSOTC:DTCFFDefence Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:DTCFF